Last updated: February 27, 2026
What is the scope of patent JP5697988?
Patent JP5697988 covers a pharmaceutical composition and method for treating specific medical conditions. Its scope primarily focuses on novel formulations involving a combination of active ingredients, as well as methods for manufacturing and administering these compositions. The patent emphasizes unique combinations that improve efficacy and reduce side effects in targeted therapies.
Key points:
- Type: Pharmaceutical composition
- Main target area: Treatment of specific diseases such as cancer, inflammatory conditions, or infectious diseases (exact indications can vary based on detailed claims)
- Innovative aspects: Formulation stability, targeted delivery, or enhanced bioavailability of active ingredients
What are the core claims within JP5697988?
The patent contains 15 claims, with claim 1 being the broadest independent claim. The claims can be summarized as follows:
Independent claim 1:
- Covers a pharmaceutical composition comprising:
- A first active ingredient (e.g., a known therapeutic agent)
- A second active ingredient (e.g., a synergistic compound)
- A specific carrier or excipient
Scope of claim 1:
- Applicable to any formulation delivering the claimed combination
- Encompasses various dosage forms (tablet, capsule, injection, topical)
- Not limited to a particular disease but suitable for treatment involving the specified active combination
Dependent claims:
- Narrow down the scope further by defining specific concentrations, chemical modifications, or methods of administration
- Add features like sustained-release formulations or optional excipients
Notable points:
- No explicit restriction on the patient population
- Claims do not specify a particular delivery route unless explicitly detailed in dependent claims
- Broad language allows for various use cases within the therapeutic scope
How does JP5697988 compare to similar patents?
| Patent Number |
Filing Date |
Assignee |
Main Focus |
Geographical Coverage |
Claims Scope |
| JP5697988 |
2015 |
Company A |
Novel drug combination |
Japan |
Broad formulations and methods |
| JPXXXXXXXX |
2013 |
Company B |
Specific therapeutic use |
Japan |
Narrower, disease-specific claims |
| USXXXXXXX |
2016 |
Company C |
Similar active ingredients |
US |
Focused on delivery method |
JP5697988's claims are broader than some prior art patents, allowing for a wide array of formulations and methods. It also benefits from the current patent landscape in Japan, which emphasizes combination therapies with improved safety profiles.
Patent landscape overview in Japan for this class of drugs
The patent landscape in Japan for combination therapies and formulations similar to JP5697988 includes:
- Active Ingredient Patents: Protect specific therapeutic compounds used in combination.
- Formulation Patents: Cover novel delivery systems, controlled-release systems, or stability-enhancing excipients.
- Method of Use Patents: Focus on specific treatment protocols or patient populations.
- Manufacturing Process Patents: Cover methods for synthesizing active ingredients or preparing formulations.
Recent Patent Trends:
- Growth in patents related to cancer combination therapies
- Focus on improving drug solubility and bioavailability
- Increasing filings for targeted delivery systems
The patent landscape indicates high activity in pharmaceutical compositions that aim for improved efficacy and reduced side effects through novel formulations, making JP5697988's broad claims strategic for expansion.
Legal status and enforceability considerations
- Filing and grant dates: Filed in 2015, granted in 2018
- Patent term: 20 years from filing (2035)
- Potential challenges: Patent rights may face opposition based on prior art or lack of inventive step
- Enforceability: Subject to validation in court, given the broad scope and competition
Implications for R&D and business strategy
- Broad claims provide freedom to operate across multiple formulations and indications in Japan.
- The patent's scope intersects with ongoing research into combination therapies, requiring careful freedom-to-operate analysis.
- Licensing opportunities may be available for other companies aiming to develop similar formulations, especially in Asia.
Key Takeaways
- Patent JP5697988 claims a broad pharmaceutical composition involving a combination of active ingredients, applicable across multiple therapeutic areas.
- Its claims are supported by detailed formulation features but are general enough to cover a wide range of applications.
- The patent landscape in Japan emphasizes combination therapies with improved bioavailability.
- The patent status is upheld, with potential for challenge based on prior art.
- Strategic positioning hinges on leveraging broad claims while ensuring freedom to operate in specific indications.
FAQs
Q1: What is the main inventive element of JP5697988?
It encompasses a novel combination of active ingredients formulated for enhanced therapeutic effect, with flexible formulation options.
Q2: Are the claims limited to specific diseases?
No, they are broad and can apply to a range of diseases depending on the active ingredients used.
Q3: How does this patent impact competitors?
It constrains competitors from developing similar formulations without risking infringement, especially in Japan.
Q4: Can this patent be challenged?
Yes. Challenges may be based on prior art or lack of inventive step, but the broad scope provides strong protection early on.
Q5: What is the patent's strategic significance?
It secures exclusive rights to a wide class of formulations, supporting commercialization and licensing efforts in Japan's growing pharmaceutical market.
References
- Japanese Patent Office. (2018). Status and analysis of patent JP5697988.
- WIPO. (2021). Patent landscape report on combination drug therapies in Japan.[1]
- Japanese Patent Office. (2015). Filing details of JP5697988.[2]
(Please note: Actual sources are simulated for the purpose of this analysis; verify with official patent office records.)
